Guidance for Implementing a Remote Assessment Strategy as a Protocol Adaptation During the COVID-19 Pandemic

Date Published:
Whitepaper

This white paper offers guidance on implementing remote ratings for studies operating during the COVID-19 crisis. Signant Health experts, Dan Debonis and Gary Sachs, discuss methods to collect data that will identify where and how remote ratings are used. They also offer principles to maximize the quantity and quality of data even while operating under conditions of uncertainty.

Learn about the important considerations regarding:

  • Legal & regulatory needs
  • Operations
  • Clinical requirements
  • Logistics
  • Safety
  • Engagement

Recommended Resources

3 Themes and Takeaways From FDA’s Draft Guidance on DCTs

Download Now
Whitepaper

Computerized Adaptive Tests Using PROMIS CAT

Download Now
Whitepaper

The EMA Recommendation Paper on Decentralized Elements in Clinical Trials: An Overview

Read Our White Paper
Whitepaper